Hib (Haemophilus influenzae type b) Vaccine bulk supplier for pharma manufacturers

Hib (Haemophilus Influenzae Type B) Vaccine 0.5 mL Suppliers & Bulk Manufacturers

Available Forms: Injectable suspension (IM injection)

Available Strengths: 0.5 mL

Reference Brands: PedvaxHIB,ActHIB(US)

Category: Vaccines

Hib vaccine stimulates the immune system to produce antibodies against Haemophilus influenzae type b bacteria. It prevents invasive diseases like meningitis, pneumonia, and sepsis, reducing morbidity and mortality. Benefits include long-lasting immunity, disease reduction, and protection of vulnerable infants and children from serious bacterial infections.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Hib (Haemophilus influenzae type b) vaccines are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and high manufacturing standards aligned with GMP standards. In the US, FDA oversight requires clinical evaluation and safety profiles, while in the EU, CE marking certifies conformity with in vitro diagnostic regulations. These vaccines undergo validation, stability testing, and comprehensive audits, with detailed documentation including safety data, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe and effective Hib vaccines, critical for preventing invasive bacterial diseases worldwide.

Hib (Haemophilus Influenzae Type B) Vaccine — third party manufacturing & bulk supply

Hib (Haemophilus Influenzae Type B) Vaccine 0.5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Hib (Haemophilus Influenzae Type B) Vaccine is supplied as Injectable suspension (IM injection) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Hib (Haemophilus Influenzae Type B) Vaccine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Hib (Haemophilus Influenzae Type B) Vacc... →

Back to Listing

Frequently Asked Questions

Hib (Haemophilus influenzae type b) Vaccine is listed as Injectable suspension (IM injection) in 0.5 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Hib (Haemophilus influenzae type b) Vaccine is referenced against PedvaxHIB,ActHIB(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.